Transaction Jun 17, 2025 · Disclosed Jan 13, 2026
8 different filers disclosed PFE within 90 days. Disclosed 210 days after the transaction; reported as an official range, not an exact amount.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
$1,001–$15,000
Official band as filed. No midpoint or exact amount is implied
Filer
210 days
Days between the transaction date and the filing date
First disclosure on this company by this filer
8 distinct filers within 90 days
Sponsored 1 bill in Health this Congress.
Bills (H.R. / S.) this member sponsored in the 119th Congress so far, including any introduced after the trade, grouped by the policy area the Congressional Research Service assigned (Congress.gov). Which policy areas relate to which sectors is OQRO's editorial mapping. Not a sign of what they knew or why they traded
4570680572!NALOXONE 4 MG/10 ml vial 10ML
The Department of Defense placed a delivery order with Pfizer for naloxone vials, committing $2.8K so far. This order was made under an existing larger agreement and was open to any bidder, making it a routine purchase.
Routine share withholding; mechanical by default.
4570622159!NALOXONE 0.4 MG/ML vialml
The Department of Defense placed a delivery order for $9,048 of naloxone vials from Pfizer on January 26, 2026. This order was made under an existing agreement and was open to any bidder, making it a routine purchase rather than a unique or unusual transaction.
